Literature DB >> 10063801

Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin.

D J Robinson1, H S de Bruijn, N van der Veen, M R Stringer, S B Brown, W M Star.   

Abstract

Fluorescence photobleaching of protoporphyrin IX (PpIX) during superficial photodynamic therapy (PDT), using 514 nm excitation, was studied in UVB-induced tumor tissue in the SKH-HR1 hairless mouse. The effects of different irradiance and light fractionation regimes upon the kinetics of photobleaching and the PDT-induced damage were examined. Results show that the rate of PpIX photobleaching (i.e., fluorescence intensity vs fluence) and the PDT damage both increase with decreasing irradiance. We have also detected the formation of fluorescent PpIX photoproducts in the tumor during PDT, although the quantity recorded is not significantly greater than generated in normal mouse skin, using the same light regime. The subsequent photobleaching of the photoproducts also occurs at a rate (vs fluence) that increases with decreasing irradiance. In the case of light fractionation, the rate of photobleaching increases upon renewed exposure after the dark period, and there is a corresponding increase in PDT damage although this increase is smaller than that observed with decreasing irradiance. The effect of fractionation is greater in UVB-induced tumor tissue than in normal tissue and the damage is enhanced when fractionation occurs at earlier time points. We observed a variation in the distribution of PDT damage over the irradiated area of the tumor: at high irradiance a ring of damage was observed around the periphery. The distribution of PDT damage became more homogeneous with both lower irradiance and the use of light fractionation. The therapeutic dose delivered during PDT, calculated from an analysis of the fluorescence photobleaching rate, shows a strong correlation with the damage induced in normal skin, with and without fractionation. The same correlation could be made with the data obtained from UVB-induced tumor tissue using a single light exposure. However, there was no such correlation when fractionation schemes were employed upon the tumor tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10063801

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  14 in total

1.  Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy.

Authors:  Asta Juzeniene; Petras Juzenas; Li-Wei Ma; Vladimir Iani; Johan Moan
Journal:  Lasers Med Sci       Date:  2004-10-16       Impact factor: 3.161

2.  Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy.

Authors:  Shannon M Gallagher-Colombo; Harry Quon; Kelly M Malloy; Peter H Ahn; Keith A Cengel; Charles B Simone; Ara A Chalian; Bert W O'Malley; Gregory S Weinstein; Timothy C Zhu; Mary E Putt; Jarod C Finlay; Theresa M Busch
Journal:  Photochem Photobiol       Date:  2015-07-02       Impact factor: 3.421

3.  Prostate PDT dosimetry.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Photodiagnosis Photodyn Ther       Date:  2006-10-19       Impact factor: 3.631

4.  Spectroscopic evaluation of photodynamic therapy of the intraperitoneal cavity.

Authors:  Jarod C Finlay; Julia L Sandell; Timothy C Zhu; Robert Lewis; Keith A Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01-23

5.  Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.

Authors:  William J Cottrell; Anne D Paquette; Kenneth R Keymel; Thomas H Foster; Allan R Oseroff
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

6.  The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.

Authors:  Marlon S Mathews; Even Angell-Petersen; Rogelio Sanchez; Chung-Ho Sun; Van Vo; Henry Hirschberg; Steen J Madsen
Journal:  Lasers Surg Med       Date:  2009-10       Impact factor: 4.025

7.  Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus.

Authors:  Brian W Pogue; Chao Sheng; Juan Benevides; David Forcione; Bill Puricelli; Norm Nishioka; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

8.  Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.

Authors:  Ken Kang-Hsin Wang; Soumya Mitra; Thomas H Foster
Journal:  Med Phys       Date:  2008-08       Impact factor: 4.071

9.  Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT.

Authors:  Ken Kang-Hsin Wang; William J Cottrell; Soumya Mitra; Allan R Oseroff; Thomas H Foster
Journal:  Lasers Surg Med       Date:  2009-11       Impact factor: 4.025

10.  In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer.

Authors:  Sami El Khatib
Journal:  Curr Urol       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.